ACROBiosystems hosted its Innovation Day in California, gathering biotech experts to explore how experimental validation supports AI-driven drug discovery workflows.
ACROBiosystems hosted an AI-focused innovation day, highlighting its role in AI-driven drug discovery but with no direct financial impact.
ACROBiosystems convened industry leaders and biotech founders in South San Francisco on October 13 to discuss the integration of artificial intelligence in pharmaceutical research. The event focused on the critical role of experimental validation in accelerating drug development pipelines.
The event focused on the intersection of artificial intelligence and drug discovery, specifically highlighting the importance of experimental validation in the research process.